Copegus
Sponsors
Hoffmann-La Roche, Mayo Clinic, Scynexis, Inc.
Conditions
Hepatitis CHepatitis C InfectionHepatitis C, ChronicLiver Transplant
Phase 2
A Study of Hepatitis C Virus (HCV) Polymerase Inhibitor Pro-Drug in Combination With PEGASYS With or Without COPEGUS in Patients With Chronic Hepatitis C (CHC) Genotype 1 Infection.
CompletedNCT00377182
Start: 2006-09-30End: 2008-08-31Updated: 2016-11-02
A Study of Hepatitis C Virus (HCV) Polymerase Inhibitor Pro-Drug in Combination With PEGASYS Plus COPEGUS Compared With PEGASYS Plus COPEGUS in Patients With Chronic Hepatitis C Genotype 1 Infection.
CompletedNCT00517439
Start: 2007-12-31End: 2010-01-31Updated: 2016-11-02
A Study of RO5024048 in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C, Genotype 1 or 4
CompletedNCT00869661
Start: 2001-02-28End: 2012-02-29Updated: 2016-11-02
A Study of RO5190591 (Danoprevir) in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1 Virus Infection
CompletedNCT00963885
Start: 2009-08-31End: 2012-01-31Updated: 2016-11-02
A Study of Danoprevir Boosted With Low Dose Ritonavir in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C Virus Infection
CompletedNCT01220947
Start: 2010-11-30End: 2012-12-31Updated: 2016-11-02
Study of SCY-635, Pegasys and Copegus in Hepatitis C
CompletedNCT01265511
Start: 2010-11-30End: 2011-10-31Updated: 2017-08-18
A Study of Danoprevir/Ritonavir and Copegus With RO5024048 and/or Pegasys in Patients With Chronic Hepatitis C
CompletedNCT01331850
Start: 2011-05-31End: 2013-01-31Updated: 2016-11-02
A Study of Mericitabine in Combination With Boceprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C
CompletedNCT01482403
Start: 2011-11-30End: 2014-01-31Updated: 2016-08-05
Phase 4
ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection.
CompletedNCT00077636
Start: 2003-12-31End: 2006-03-31Updated: 2016-02-23
PHOENIX Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) Administered After Liver Transplantation for Hepatitis C.
CompletedNCT00087633
Start: 2004-10-31End: 2008-10-31Updated: 2018-03-29
Safety and Effectiveness Using Pegasys and Copegus in Recipients of Liver Transplantation With Hepatitis C
CompletedNCT00275548
Start: 2004-07-31End: 2009-04-30Updated: 2011-11-11
SYREN Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin) in Non-Responder Patients With Chronic Hepatitis C (CHC) Genotype 1.
CompletedNCT00412334
Start: 2007-01-31End: 2010-09-30Updated: 2016-04-05
A Study of Extended Therapy of PEGASYS (Peginterferon Alfa-2a) in Combination With COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C and Slow Response
CompletedNCT01033448
Start: 2009-12-31End: 2013-06-30Updated: 2017-10-03